The funds will be used to expand the company’s headcount and enhance datasets. Zephyr AI’s current target areas are in oncology and cardiometabolic diseases. Image credit: Shutterstock/NicoElNino. The startup funding landscape for deep technology companies in healthcare is burgeoning and Zephyr AI is no exception to this trend. The US company has closed a $111m Series A financing round to advance its artificial intelligence (AI) platform that helps generate insights into improving patient care a...